Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ventas, Inc. (NYSE: VTR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a healthcare-focused S&P 500 real estate investment trust. Through these filings, investors can review how Ventas reports on its portfolio of approximately 1,400 properties in North America and the United Kingdom, including senior housing communities, outpatient medical buildings, research centers and other healthcare facilities.
Current and historical Forms 8-K offer detailed information about material events affecting Ventas and its subsidiaries. Recent 8-K filings describe items such as the pricing and issuance of senior notes by Ventas Realty, Limited Partnership, amendments to unsecured term loan facilities guaranteed by Ventas, and announcements of quarterly results. These documents help readers understand the company’s capital structure, borrowing arrangements and operating performance disclosures.
Other SEC filings, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, provide broader context on Ventas’s business, risk factors, REIT structure and segment performance. For a healthcare REIT like Ventas, these reports typically include discussions of its senior housing operating portfolio, outpatient medical and research assets, and the demographic and regulatory environment relevant to its properties.
Investors can also use SEC filings to track matters such as dividend practices, debt covenants, and the terms of public offerings or credit agreements. On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections and surface important changes across reporting periods, helping users interpret complex documents more efficiently. Real-time updates from the SEC’s EDGAR system mean that new Ventas filings, including 10-K, 10-Q, 8-K and related exhibits, are available promptly, while Form 4 and other ownership reports can be consulted to analyze insider transactions and equity-based compensation activity associated with VTR.
Ventas, Inc. director Maurice S. Smith received an award of 457.261 common stock units on April 1, 2026 under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. The units were granted in lieu of director fees and are payable solely in common stock.
The grant was valued at $82.01 per share, representing the closing price of Ventas common stock on the grant date. Following this compensation-related acquisition, Smith directly holds a total of 28,549.613 shares of Ventas common stock.
Roy Sumit reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Sumit Roy received an award of 381.051 shares of common stock on April 1, 2026. The shares were granted as units under the company’s Non-Employee Directors' Cash Compensation Deferral Plan in lieu of cash director fees, based on a closing share price of $82.01. After this compensation-related grant, Roy directly holds a total of 22,240.765 shares of Ventas common stock.
LUSTIG MATTHEW J reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Matthew J. Lustig received an automatic grant of 396.293 shares of common stock-equivalent units on 2026-04-01. These units were awarded under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan in lieu of cash director fees he elected to defer.
The units are payable solely in Ventas common stock and are subject to the terms of his deferral election and the plan. After this award, Lustig directly holds a total of 92,662.739 shares of Ventas common stock, reflecting his ongoing equity-based compensation as a board member.
Ventas, Inc. director Roxanne M. Martino received a grant of common stock units under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. She acquired 624.924 common stock units in lieu of director fees at a reference price of $82.01 per share, increasing her direct holdings to 63,892.701 shares. The granted units are payable solely in common stock and are subject to the terms of her deferral election and the plan.
Ventas, Inc. presents its 2026 proxy, highlighting very strong 2025 performance and key governance votes. The company reports total shareholder return above 35% for 2025 and about 19% annualized since 2000, significantly outperforming major REIT and equity indices over multiple periods.
Financially, 2025 net income per share rose to $0.54, while Nareit FFO and Normalized FFO per share increased to $3.50 and $3.48, reflecting 11% and 9% growth. Total Company NOI grew 16% and Same-Store Cash NOI grew 8%, supported by demographic-driven demand in senior housing.
The proxy asks stockholders to elect 12 directors, approve executive compensation on an advisory basis and ratify KPMG as auditor for 2026. Ventas emphasizes a largely independent board, an experienced Lead Independent Director, robust succession planning, and compensation programs designed to align more than 80% of named executive officer target pay with performance and shareholder outcomes.
Ventas Inc: Schedule 13G/A amendment showing The Vanguard Group reports no beneficial ownership. The filing states 03/13/2026 and the amendment was signed 03/27/2026. It reports 0 shares beneficially owned and 0% of the class, with zero voting and dispositive power.
The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 causing certain Vanguard subsidiaries/divisions to report holdings separately. The statement clarifies Vanguard no longer is deemed to beneficially own securities held by those subsidiaries/divisions.
Ventas, Inc. submitted a Form 144 proposing the sale of common stock through UBS Financial Services Inc. on the NYSE, with the filing dated 03/02/2026. The filing lists ESOP-related lots dated 03/04/2016 (6,953 shares) and 03/10/2017 (10,295 shares).
Ventas, Inc. reported that Gregory R. Liebbe, its Senior Vice President, Chief Accounting Officer and Controller, has resigned to pursue other opportunities, with his last day on February 27, 2026. The company states that his decision is not due to any disagreement regarding accounting practices or financial reporting.
Executive Vice President and Chief Financial Officer Robert F. Probst will take on the role of Chief Accounting Officer on an interim basis while Ventas conducts a comprehensive search for a permanent successor. The company highlighted Mr. Liebbe’s approximately 20 years of service, including 10 years as Chief Accounting Officer.
Ventas, Inc. filed a Form 13F reporting institutional holdings with a total market value of $82,494,284. The report lists 1 information table entry and states there are 0 other included managers.